Skip to main content
logo
T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,230.00
-45.00 (-1.98%)
Sep 21, 2026, 3:30 PM KST

T&R Biofab Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
32,73226,9674,8745,199
Revenue Growth
120.91%453.32%-6.26%-
Gross Profit
10,1986,8282,1081,048
Operating Income
-5,255-8,668-13,299-12,853
Net Income
-27,712-31,951-7,679-13,419
Earnings Per Share
-614.92-999.32-297.00-527.37
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
6,1297,86117,27651,747
Total Debt
30,52929,56246,05646,021
Net Cash (Debt)
-24,401-21,702-28,7805,725
Net Cash Growth
----
Net Cash Per Share
-541.45-678.76-1113.17225.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-2,251-7,466-11,733-6,963
Capital Expenditures
-2,301-2,146-2,576-12,493
Free Cash Flow
-4,552-9,612-14,309-19,456
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
31.16%25.32%43.24%20.16%
Operating Margin
-16.05%-32.14%-272.87%-247.22%
Pretax Margin
-84.66%-118.48%-157.55%-258.10%
Profit Margin
-84.66%-118.48%-157.56%-258.10%
FCF Margin
-13.91%-35.64%-293.60%-374.22%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PS Ratio
3.256.6519.1736.97